Ray Elliott, Boston Scientific’s CEO, said Medtronic’s Protecta implantable defibrillator is a “catch-up product” and called one of St. Jude’s new products “99 percent hype.”Boston Scientific CEO Ray Elliott slammed products made by two of the state’s largest medical device manufacturers—Medtronic, Inc., and St. Jude Medical, Inc.—at Monday’s 36th annual Deutsche Bank Securities, Inc., Health Care Conference.
During his presentation, Elliott said that Medtronic’s Protecta implantable defibrillator is a “catch-up product,” adding that Boston Scientific has had the technology since 2008.
